drugset / Trial / NCT00719498

Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)

NCT00719498 ↗

Phase 3 Completed 20 enrolled Janssen Cilag S.A.S.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test the possible neuroprotective effect of early high dose erythropoietin alpha after out of hospital cardiac arrest (OHCA).

Timeline

Start
2003-11
Primary completion
—
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Epo-alpha Unknown 40000 iu Intravenous

Indications